IDiyas

For the Inventor, By the Inventor

Pennington, NJ, United States of America

Rulin Zhao

USPTO Granted Patents = 23 

 

Average Co-Inventor Count = 4.5

ph-index = 5

Forward Citations = 57(Granted Patents)


Company Filing History:

goldMedal18 out of 3,681 
 
Bristol-myers Squibb Compnay
 patents
silverMedal5 out of 1,309 
 
Wyeth
 patents
bronzeMedal1 out of 97 
 
Albany Molecular Research, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2002-2020

Loading Chart...
Loading Chart...
23 patents (USPTO):
1. 10604541 - Glucokinase activators and methods of using same (2020-03-31),
2. 8420811 - Tetrahydroisoquinolines and intermediates therefor (2013-04-16),
3. 8049019 - Substituted pyrrolidine-2-one compounds (2011-11-01),
4. 7652146 - Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors (2010-01-26),
5. 7629351 - [object Object] (2009-12-08),
6. 7605273 - Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors (2009-10-20),
7. 7579472 - Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones (2009-08-25),
8. 7435821 - Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones (2008-10-14),
9. 7396935 - Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors (2008-07-08),
10. 7304157 - Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones (2007-12-04),
11. 7034151 - Process for preparing pyrrolotriazine kinase inhibitors (2006-04-25),
12. 7030245 - Antidepressant azahetorocyclylmethyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenathrene (2006-04-18),
13. 6930109 - Antidepressant azaheterocyclyl methyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene (2005-08-16),
14. 6906192 - Processes for the preparation of acid derivatives useful as serine protease inhibitors (2005-06-14),
15. 6903110 - Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene (2005-06-07),

Title: Rulin Zhao: Innovator in Pharmaceutical Patents

Introduction

Rulin Zhao is a prominent inventor based in Pennington, NJ, recognized for his significant contributions to pharmaceutical innovations. With an impressive portfolio of 23 patents, Zhao has been instrumental in advancing methods for treating major health issues, particularly diabetes and depression.

Latest Patents

Among his latest patents, Rulin Zhao developed glucokinase activators, which serve as potential treatments for diabetes and related diseases. The patent details a compound that acts as an activator of the enzyme glucokinase, demonstrating its therapeutic potential. Another recent patent involves the synthesis of tetrahydroisoquinolines and their intermediates. This innovation outlines processes for preparing these compounds, along with their use in treating depression and related conditions.

Career Highlights

Rulin Zhao has had a distinguished career working with leading pharmaceutical companies, including Bristol-Myers Squibb Company and Wyeth. His expertise in drug development and patent articulation has propelled advancements in therapeutic applications, establishing him as a key figure in the industry.

Collaborations

Throughout his career, Zhao has collaborated with notable colleagues, including Bang-Chi Chen and Joseph E. Sundeen. Their combined efforts have fostered innovative approaches in research, leading to the creation of effective pharmaceutical solutions.

Conclusion

Rulin Zhao's contributions in the field of innovative healthcare solutions exemplify the vital role of inventors in addressing pressing health challenges. His patents not only reflect his innovative spirit but also underscore the importance of collaboration within the scientific community to enhance patient care and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…